The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
Coen O, Corrie P, Marshall H, Plummer R, Ottensmeier C, Hook J, Bell S, Sagoo GS, Meads D, Bestall J, Velikova G, Gallagher FA, Smith A, Howard H, Mason E, Katona E, Silva S, Collinson M, Rodwell S, Danson S.
Coen O, et al. Among authors: mason e.
BMC Cancer. 2021 Jul 1;21(1):761. doi: 10.1186/s12885-021-08509-w.
BMC Cancer. 2021.
PMID: 34210290
Free PMC article.
Clinical Trial.